These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Safety, tolerability, and pharmacokinetics of KNS-760704 (dexpramipexole) in healthy adult subjects. Bozik ME; Mather JL; Kramer WG; Gribkoff VK; Ingersoll EW J Clin Pharmacol; 2011 Aug; 51(8):1177-85. PubMed ID: 20959524 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of glucocorticoid resistance in hypereosinophilic syndromes. Stokes K; Yoon P; Makiya M; Gebreegziabher M; Holland-Thomas N; Ware J; Wetzler L; Khoury P; Klion AD Clin Exp Allergy; 2019 Dec; 49(12):1598-1604. PubMed ID: 31657082 [TBL] [Abstract][Full Text] [Related]
12. A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma. Busse WW; Ring J; Huss-Marp J; Kahn JE J Allergy Clin Immunol; 2010 Apr; 125(4):803-13. PubMed ID: 20371394 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes. Dispenza MC; Bochner BS Curr Hematol Malig Rep; 2018 Jun; 13(3):191-201. PubMed ID: 29680938 [TBL] [Abstract][Full Text] [Related]
14. Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms. Osowo A; Fetten J; Navaneethan S South Med J; 2006 Feb; 99(2):188-9. PubMed ID: 16509562 [TBL] [Abstract][Full Text] [Related]
15. Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis. Cheah BC; Kiernan MC IDrugs; 2010 Dec; 13(12):911-20. PubMed ID: 21154151 [TBL] [Abstract][Full Text] [Related]
16. [The hypereosinophilic syndrome: case report]. Mikołajczyk K; Zaba R; Walkowiak B; Grzybowski G; Samborski W Ann Acad Med Stetin; 2006; 52 Suppl 2():65-9. PubMed ID: 17471838 [TBL] [Abstract][Full Text] [Related]
17. A case of myeloid neoplasm associated with eosinophilia and KIAA1509-PDGFRβ responsive to combination treatment with imatinib mesylate and prednisolone. Wang JR; Yen CC; Gau JP; Hsiao LT; Liu CY; Pai JT; Tzeng CH; Teng HW J Clin Pharm Ther; 2010 Dec; 35(6):733-6. PubMed ID: 21054467 [TBL] [Abstract][Full Text] [Related]
18. Dexpramipexole: a new antieosinophil drug? Gleich GJ Blood; 2018 Aug; 132(5):461-462. PubMed ID: 30072411 [No Abstract] [Full Text] [Related]
19. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab. Schwartz LB; Sheikh J; Singh A Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230 [TBL] [Abstract][Full Text] [Related]
20. Childhood idiopathic hypereosinophilic syndrome: report of a case. Kao CC; Ou LS; Lin SJ; Huang JL Asian Pac J Allergy Immunol; 2002 Jun; 20(2):121-6. PubMed ID: 12403197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]